Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer

Lung cancer remains a leading cause of cancer mortality worldwide, including in Korea. Systemic therapy including platinum-based chemotherapy and targeted therapy should be provided to patients with stage IV non-small cell lung cancer (NSCLC). Applications of targeted therapy, such as an epidermal g...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sung Won, Ahn, Myung-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325449/
https://www.ncbi.nlm.nih.gov/pubmed/30612418
http://dx.doi.org/10.3904/kjim.2018.179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325449/
https://www.ncbi.nlm.nih.gov/pubmed/30612418
http://dx.doi.org/10.3904/kjim.2018.179

Ejemplares similares